Overview
MiNK Therapeutics, Inc. is a publicly traded company headquartered in New York City [1]. The company is listed on the Nasdaq exchange under the ticker symbol INKT [2]. According to Securities and Exchange Commission filings, MiNK Therapeutics operates in the biological products industry, excluding diagnostic substances [3]. The company was previously registered with the SEC under the name AgenTus Therapeutics, Inc. [4]. As of its most recent annual report, MiNK Therapeutics reported total assets of $14.2 million [5].
Business address: 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010. [1]
Financials
Reported total assets of $14.2 million in its most recent annual report to the SEC. [5]
Something wrong or missing? Send an update. Fixed within 24 hours.